Bousfiha, Aziz
Moundir, Abderrahmane
Tangye, Stuart G.
Picard, Capucine
Jeddane, Leïla
Al-Herz, Waleed
Rundles, Charlotte C.
Franco, Jose Luis
Holland, Steven M.
Klein, Christoph
Morio, Tomohiro
Oksenhendler, Eric
Puel, Anne
Puck, Jennifer
Seppänen, Mikko R. J.
Somech, Raz
Su, Helen C.
Sullivan, Kathleen E.
Torgerson, Troy R.
Meyts, Isabelle
Funding for this research was provided by:
Division of Intramural Research, National Institute of Allergy and Infectious Diseases
CSL Behring
Baxalta
Shire
Takeda Pharmaceuticals U.S.A.
CSL Behring Chair of Primary Immunodeficiencies
Onderzoeksraad, KU Leuven (C1 Grant C16/18/007)
GC Europe (VIB GC PID Grant)
Research Foundation - Flanders (G0C8517N, G0B5120N, G0E8420N)
Jeffrey Modell Foundation
H2020 European Research Council (948959)
ERN-RITA
Article History
Received: 18 May 2022
Accepted: 14 August 2022
First Online: 6 October 2022
Declarations
:
: No human research studies were performed to produce this classification. Thus, no approvals by appropriate institutional review boards or human research ethics committees were required to undertake the preparation of this report.
: Not applicable.
: Not applicable.
: The authors declare no competing interests.